A double-blind, randomised, placebo-controlled study in 45 women with pregnancy gingivitis showed that supplementation of L. reuteri Prodentis significantly reduced inflammation and plaque compared to placebo.
“Our study shows that L. reuteri containing lozenges may be a valuable adjunct in the control of pregnancy gingivitis”, says Professor Ulrich Schlagenhauf, Department of Periodontology, University Hospital Würzenburg, Germany.
45 healthy women with pregnancy gingivitis were enrolled at the beginning of their third trimester. Participants were randomly provided with a supply of lozenges to be consumed twice daily until birth (approximately three months), each containing 5 x10^8 cfu of L. reuteri Prodentis or an equivalent placebo. At the end of the intervention period both gingival index and plaque index of the probiotics group were significantly (p < 0.0001) lower than in the placebo group.
To view the full story, please visit: http://www.businesswire.com/news/home/20160808005388/en/BioGaia-BioGaia%E2%80%99s-Oral-Health-Probiotic-Reduces-Pregnancy
